Company profile: Opterion
1.1 - Company Overview
Company description
- Provider of innovations in dialysis care, fostering home dialysis to improve quality of life for ESRD patients. Products include Opt100, a new osmotic driver for peritoneal dialysis composed of short glucose polymers and maltose to minimize metabolic challenges and allow flexible dwell times, and a biocompatibility enhancing agent with resveratrol to reduce cytotoxicity and inflammation.
Products and services
- Biocompatibility Enhancing Agent (BCA): A clinical-grade adjunct including resveratrol that targets reduced cytotoxicity and inflammation in peritoneal dialysis solutions to improve biocompatibility
- Home Dialysis Innovation & Fostering: A home-centric initiative architected to advance dialysis-at-home uptake, improve patient and caregiver quality of life, and potentially increase ESRD survival rates
- Opt100: A custom-engineered osmotic driver for peritoneal dialysis composed of short glucose polymers and maltose, minimizing metabolic challenges and enabling flexible dwell times
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Opterion
Potrero Medical
HQ: United States
Website
- Description: Provider of predictive health technologies developing smart sensors and AI, including the Accuryn Monitoring System for real-time monitoring of urine output, intra-abdominal pressure, and core body temperature to detect acute kidney injury risk; AccuTab software for visualizing and annotating data; and Accuryn SmartFoley catheters designed to reduce CAUTIs by preventing urine backflow.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Potrero Medical company profile →
Outset Medical
HQ: United States
Website
- Description: Provider of dialysis technology, including the Tablo Hemodialysis System for treating acute and chronic renal failure in hospitals and at home, featuring integrated water purification, touchscreen interface, and multiple dialysis modalities; TabloHub for two-way data transmission and remote patient monitoring; EMR Connect for EMR integration and automated documentation; and TabloCart for device transportation within clinical settings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Outset Medical company profile →
A1M Pharma
HQ: Sweden
Website
- Description: Provider of alpha 1 microglobulin, a body protein that is of major importance for the body's defense against oxidative stress.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full A1M Pharma company profile →
Theradial
HQ: France
Website
- Description: Provider of medical devices in France serving health actors in dialysis-nephrology, gastroenterology and onco-hematology. Offers Renoral nutritional supplement for hemodialysis patients; Hemadialyse and MEDWARE software for patient data/records; Théradata CNIL-authorized nephrology-dialysis data repository; InBody S10 and InBody BWA 2.0 bioimpedance analyzers, and partners with the medical and scientific community via clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Theradial company profile →
MediBeacon
HQ: United States
Website
- Description: Provider of optical diagnostic solutions for non-invasive organ function measurement, including the Transdermal GFR Measurement System (TGFR) that assesses kidney function via a fluorescent tracer (Lumitrace) detected through the skin, plus TGFR Sensors and Monitors for real-time data. Also offers novel fluorescent tracer agents and highly engineered transdermal sensors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MediBeacon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Opterion
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Opterion
2.2 - Growth funds investing in similar companies to Opterion
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Opterion
4.2 - Public trading comparable groups for Opterion
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →